Wellington Management Group
CPRX

Wellington Management Group’s Catalyst Pharmaceutical CPRX Stock Holding History

Wellington Management Group’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.16M Sell
46,817
-3,095
-6% -$73.7K ﹤0.01% 1648
2025
Q4 		$1.16M Sell
49,912
-3,066
-6% -$68.3K ﹤0.01% 1695
2025
Q3 		$1.04M Buy
52,978
+6,619
+14% +$136K ﹤0.01% 1770
2025
Q2 		$1.01M Sell
46,359
-2,088
-4% -$49.3K ﹤0.01% 1721
2025
Q1 		$1.17M Sell
48,447
-3,103
-6% -$69.9K ﹤0.01% 1669
2024
Q4 		$1.08M Sell
51,550
-8,034
-13% -$173K ﹤0.01% 1702
2024
Q3 		$1.18M Buy
+59,584
New +$1.1M ﹤0.01% 1677
2023
Q2 		– Sell
-121,575
Closed -$2.02M – 1840
2023
Q1 		$2.02M Buy
121,575
+9,211
+8% +$152K ﹤0.01% 1512
2022
Q4 		$2.09M Buy
112,364
+50,650
+82% +$780K ﹤0.01% 1504
2022
Q3 		$792K Sell
61,714
-108,696
-64% -$1.29M ﹤0.01% 1698
2022
Q2 		$1.19M Sell
170,410
-503
-0.3% -$3.69K ﹤0.01% 1646
2022
Q1 		$1.42M Sell
170,913
-3,301
-2% -$23.3K ﹤0.01% 1676
2021
Q4 		$1.18M Buy
+174,214
New +$1.15M ﹤0.01% 1774

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Wellington Management Group's CPRX Position: Q1 2026 in Review

Wellington Management Group reduced its Catalyst Pharmaceutical (CPRX) stake by 6.2% in Q1 2026, selling an estimated $73.7K and leaving 46,817 shares worth $1.16M. The position accounts for ﹤0.01% of the portfolio, ranked #1648.

Wellington Management Group first reported a position in CPRX in Q4 2021 and has held it in 13 quarters since. The position peaked at $2.09M in Q4 2022. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • Wellington Management Group held 46,817 shares of Catalyst Pharmaceutical worth $1.16M as of Q1 2026.
  • Wellington Management Group sold 3,095 Catalyst Pharmaceutical shares in Q1 2026, an estimated $73.7K.
  • Catalyst Pharmaceutical made up ﹤0.01% of Wellington Management Group's portfolio in Q1 2026, its #1648 holding.
  • Wellington Management Group first reported a position in Catalyst Pharmaceutical in Q4 2021 and has held it in 13 quarters since.
  • Wellington Management Group's Catalyst Pharmaceutical position peaked at $2.09M in Q4 2022.
  • 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.